References
- Carding SR, Egan PJ Gammadelta T cells: functional plasticity and heterogeneity. Nat Rev Immunol 2002; 2: 336–245.
- Vega F, Medeiros LJ, Gaulard P. Hepatosplenic and other gammadelta T-cell lymphomas. Am J Clin Pathol 2007; 127: 869–880.
- Arnulf B, Copie-Bergman C, Delfau-Larue MH et al. Nonhepatosplenic gammadelta T-cell lymphoma: a subset of cytotoxic lymphomas with mucosal or skin localization. Blood 1998; 91: 1723–1731.
- Zhang Y, Ohyashiki JH, Takaku T, Shimizu N, Ohyashiki K. Transcriptional profiling of Epstein-Barr virus (EBV) genes and host cellular genes in nasal NK/T-cell lymphoma and chronic active EBV infection. Br J Cancer 2006; 94: 599–608.
- Ohshima K, Kimura H, Yoshino T et al. CAEBV Study Group: proposed categorization of pathological states of EBV-associated T/natural killer-cell lymphoproliferative disorder (LPD) in children and young adults: overlap with chronic active EBV infection and infantile fulminant EBV T-LPD. Pathol Inter 2008; 58: 209–217.
- Miyazaki K, Yamaguchi M, Imai H et al. Gene expression profiling of peripheral T-cell lymphoma including {gamma} {delta} T-cell lymphoma. Blood 2008; 113: 1071–1074.
- Zhang Y, Nagata H, Ikeuchi T et al. Common cytological and cytogenetic features of Epstein-Barr virus (EBV)-positive natural killer (NK) cells and cell lines derived from patients with nasal T/ NK-cell lymphomas, chronic active EBV infection and hydroa vacciniforme-like eruptions. Br J Haematol 2003; 121: 805–814.
- Oyoshi MK, Nagata H, Kimura N et al. Preferential expansion ofVgamma9-JgammaPNdelta2-Jdelta3 gammadelta T cells in nasal T-cell lymphoma and chronic active Epstein-Barr virus infection. Am J Pathol 2003 162: 1629–1638.
- Sato K, Kimura S, Segawa H et al. Cytotoxic effects of gammadelta T cells expanded ex vivo by a third generation bisphosphonate for cancer immunotherapy. Int J Cancer 2005; 116: 94–99.
- Ohyashiki JH, Hisatomi H, Nagao K et al. Quantitative relation-ship between functionally active telomerase and major telomerase components (hTERT and hTR) in acute leukaemia cells. Br J Cancer 2005; 92: 1942–1947.
- Birkenbach M, Josefsen K, Yalamanchili R, Lenoir G, Kieft' E. Epstein-Barr virus-induced genes: first lymphocyte-specific G protein-coupled peptide receptors. J Virol 1993; 67: 2209–2220.
- Sallusto F, Lanzavecchia A. Understanding dendritic cell and T-lymphocyte traffic through the analysis of chemokine receptor expression. Immunol Rev 2000; 177: 134–140.
- Nagato T, Kobayashi H, Kishibe K et al. Expression of interleukin-9 in nasal natural killer/T-cell lymphoma cell lines and patients. Clin Cancer Res 2005; 11: 8250–8257.
- Jansen CA, Cruijsen CW, de Ruiter T et al. Regulated expression of the inhibitory receptor LAIR-1 on human peripheral T cells during T cell activation and differentiation. Eur J Immunol 2007; 37: 914–924.
- Tassi I, Klesney-Tait J, Colonna M. Dissecting natural killer cell activation pathways through analysis of genetic mutations in human and mouse. Immunol Rev 2006; 214: 92–105.
- Leung W, Iyengar R, Triplett B et al. Comparison of killer Ig-like receptor genotyping and phenotyping for selection of allogeneic blood stem cell donors. J Immunol 2005; 174: 6540–6545.
- Vivier E, Anfossi N. Inhibitory NK-cell receptors on T cells: witness of the past, actors of the future. Nat Rev Immunol 2004; 4: 190–198.
- Halary F, Peyrat MA, Champagne E et al. Control of self-reactive cytotoxic T lymphocytes expressing gamma delta T cell receptors by natural killer inhibitory receptors. Eur J Immunol 1997; 27: 2812–2821
- Voehringer D, Blaser C, Brawand P et al. Viral infections induce abundant numbers of senescent CD8 T cells. J Immunol 2001; 167: 4838–4843.
- Robbins SH, Nguyen KB, Takahashi N et al. Inhibitory functions of the killer cell lectin-like receptor G1 molecule during the activation of mouse NK cells. J Immunol 2002; 168: 2585–2589.